support@activebiopharma.com
中文版
Menu
主页
产品目录
Inhibitors
AKT Inhibitors
ALK Inhibitor
ATM Inhibitor
Aurora Kinase Inhibitors
Bcl-2 Protein Family Inhibitors
B-Raf inhibitors
CDK inhibitors
c-Met Inhibitors
EGFR inhibitor
HDAC Inhibitors
Hedgehog inhibitor
HIV Inhibitor
JAK inhibitor
MEK inhibitor
mTOR Inhibitor
PARP inhibitor
PI3K Inhibitor
PKC Inhibitor
PLK1 Inhibitor
Other inhibitors
Activator
Agonist
antagonist
API
Aurora
Metabolic Disease
VEGFR-PDGFR
Other Intermediate
Others
MOF Chemicals
关于我们
定制合成
订单和支付
联系我们
Cas号索引 5
主页
/
Cas号索引 5
Cas号索引
1
2
3
4
5
6
7
8
9
产品名字索引
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
CAS
化学名称
编号
分子式
511-67-1
5,5-二溴巴比妥酸
ABP001330
C4H2Br2N2O3
52010-97-6
对羟基甲基苯甲醛
ABP001327
C8H8O2
55052-28-3
4-氯-7-氮杂吲哚
ABP001322
C7H5ClN2
50332-66-6
3-硝基-4-羟基喹啉
ABP001303
C9H6N2O3
577777-20-9
氮杂环丁-3-基(甲基)氨基甲酸叔丁酯盐酸盐
ABP001295
C9H18N2O2.ClH
5308-63-4
1-(5-甲基吡啶-2-基)乙酮
ABP001270
C8H9NO
51372-29-3
左布地奈德
ABP001249
C25H34O6
57830-14-5
5-苯氧基异苯并呋喃-1-(3H)-酮
ABP001242
C14H10O3
57233-86-0
(R)-α-甲基-4-硝基苯甲胺盐酸盐
ABP001235
C8H10N2O2.ClH
590417-95-1
6-溴-2-甲基-2H-吲唑
ABP001218
C8H7BrN2
50593-24-3
5-氨基-1-甲基-1H-吲唑
ABP001213
C8H9N3
501951-42-4
N-(2-溴苯基)-N'-[(3R)-1-[5-(三氟甲基)-2-吡啶基]-3-吡咯烷基]脲
ABP001195
C17H16BrF3N4O
53568-05-1
8-羟基-3,4-二氢-1H-2-萘酮
ABP001139
C10H10O2
59564-78-2
环酸
ABP001137
C19H18N2O5
51067-38-0
4-苯氧基苯基硼酸
ABP001128
C12H11BO3
55804-65-4
香豆素 343
ABP001118
C16H15NO4
57717-80-3
CGP 7930
ABP001026
C19H32O2
533884-09-2
(3AS,4R,9BR)-1,2,3,3A,4,9B-六氢-4-(4-羟基苯基)环戊并[C][1]苯并吡喃-8-醇
ABP000948
C18H18O3
501919-59-1
2-羟基-4-[[2-[[(4-甲基苯基)磺酰基]氧基]乙酰基]氨基]苯甲酸
ABP000942
C16H15NO7S
571190-30-2
PD-0332991/PD0332991,PD332991
ABP000842
C24H29N7O2
538-79-4
Metanicotine/TC-2403-12/TC-2403/RJR-2403 /
ABP000794
C10H14N2
57477-39-1
3-(1-甲基-4-哌啶基)-1H-吲哚-5-醇
ABP000792
C14H18N2O
50-33-9
苯基丁氮酮
ABP000789
C19H20N2O2
« 上一页
68
69
70
71
72
73
74
75
76
77
下一页 »
Cas号索引
1
2
3
4
5
6
7
8
9
产品名字索引
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Copyright © 2015-2025 活性医药. All rights reserved. Support by
Moldb
.
浙ICP备11021315号-3
浙公网安备 33010802003999号
Scroll